Emerald
supercomputer targets drug resistant virus
20 July
2012
Emerald,
the new supercomputer launched at STFC’s Rutherford Appleton Laboratory on 3
July 2012, is playing a vital role in helping scientists from the University of
Bristol understand why antiviral drugs are becoming less effective.
In an
interview with the science omega.com, Professor Adrian Mulholland, co-lead of
the study, described how Emerald’s intense computing power was helping to
create molecular dynamics simulations of the H1N1 ‘swine flu’ virus.
The article
goes on to explain how the team is using about a quarter of Emerald’s 372
Graphics Processing Units (GPUs) allowing vast improvements to the scale of
their study and enabling them to analyse
the molecular dynamics simulations much faster than they were previously able
to.
source:
The full
article is available to read on the Science Omega website:
Simulating the future for flu drugs